In addition, it addresses the FDA’s communications with the applicant, the retention of information that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer ownership of an SE report to a new applicant and electronic submission of your SE report and amen